查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲藥物輸送市場預測至 2028 年 - COVID-19 影響和區域分析 - 按給藥途徑、配銷通路和最終用戶
市場調查報告書
商品編碼
1375088

南美洲和中美洲藥物輸送市場預測至 2028 年 - COVID-19 影響和區域分析 - 按給藥途徑、配銷通路和最終用戶

South & Central America Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Route of Administration, Distribution Channel, and End User
出版日期: | 出版商: The Insight Partners | 英文 228 Pages | 訂單完成後即時交付

價格

南美洲和中美洲給藥市場預計將從2023年的10918907萬美元成長到2028年的14287669萬美元。預計2023年至2028年年複合成長率為5.5%。

對非侵入性給藥系統不斷成長的需求推動了南美洲和中美洲給藥市場

非侵入性藥物遞送通常是指穿過黏膜表面或皮膚的生物屏障的無痛藥物遞送方法。這種藥物傳遞方法可以改善藥物的取得、治療方案的依從性以及更好的藥物安全性。由於與注射給藥相比具有明顯的優勢，患者更喜歡非侵入性給藥途徑。研究發現，透過非侵入性方法給藥時，患者的依從性要高得多，因為他們在手術過程中感受到的疼痛減輕了。隨著醫療設備和經皮給藥技術的改進，非侵入性給藥方式現已準備好與傳統的口服和注射給藥途徑競爭。局部給藥、經皮主動給藥（裝置輔助增強滲透）、經皮被動給藥、經眼膜、跨黏膜以及吸入藥物經由肺泡膜給藥是一些流行的非侵入性給藥方法。

低排斥率、易於給藥、便利性和耐用性使 TDDS 成為最具吸引力的藥物傳遞方法。除了醫療機構的藥物管理之外，TDDS 還可用於護膚行業的不同程序。由於此方法主要涉及局部給藥，因此可以防止藥物非特異性地遞送至非標靶組織。 TDDS 的發展可能有助於控制心血管和中樞神經系統疾病、遺傳性疾病、糖尿病、神經肌肉疾病和傳染病（包括局部疾病）的盛行率，同時推動疫苗接種的進步和患者對長期自我給藥的偏好- 長期治療。

透過非侵入性方法輸送藥物涉及減少給藥頻率和簡化給藥方案。此外，這些輸送系統可以顯著降低臨床使用成本，因為患者可以透過這些方法自行給藥。在許多情況下，採用非侵入性給藥系統的藥物的製造成本低於注射劑的生產成本。例如，吸入胰島素已成為治療糖尿病的耐受性良好且首選的方式。因此，對非侵入性藥物輸送系統不斷成長的需求推動了藥物輸送系統市場的成長。

南美洲和中美洲藥物輸送市場概述

南美洲和中美洲的藥物輸送市場分為巴西、阿根廷以及南美洲和中美洲的其他地區。由於醫療設備進口的增加、需要先進醫療技術的醫療保健系統的不斷發展、慢性病發病率的增加以及老年人口的增加，預計該地區的市場將會成長。

南美洲及中美洲藥物輸送市場收入及 2028 年預測（百萬美元）

南美洲和中美洲藥物輸送市場細分

南美洲和中美洲給藥市場分為給藥途徑、配銷通路、最終用戶和國家。

根據給藥途徑，南美洲和中美洲給藥市場分為注射給藥、口服給藥、經黏膜給藥、局部給藥、植入式給藥和眼部給藥。 2023 年，注射給藥市場在南美洲和中美洲給藥市場中佔據更大佔有率。

根據配銷通路，南美洲和中美洲給藥市場分為醫院藥房、零售藥房和網路藥房。 2023 年，醫院藥局部門在南美洲和中美洲給藥市場中佔據最大佔有率。

根據最終用戶，南美洲和中美洲給藥市場分為醫院和診所、家庭護理機構和其他最終用戶。 2023 年，醫院和診所領域在南美洲和中美洲給藥市場中佔據最大佔有率。

根據國家/地區，南美洲和中美洲的給藥市場分為巴西、阿根廷以及南美洲和中美洲的其他地區。 2023 年，巴西在南美洲和中美洲給藥市場中佔據主導地位。

Bausch Health Companies Inc、Baxter International Inc、Becton Dickinson and Co、勃林格殷格翰國際有限公司、波士頓科學公司、Gerresheimer AG、葛蘭素史克Plc、強生公司、諾華公司、諾和諾德公司和輝瑞公司是在該領域營運的領先公司。南美洲和中美洲藥物輸送市場。

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 南美洲和中美洲藥物輸送市場 - 按給藥途徑
    • 南美洲和中美洲藥物傳輸市場 - 按配銷通路
    • 南美洲和中美洲藥物傳輸市場 - 按最終用戶分類
    • 南美洲和中美洲藥物輸送市場 - 按國家/地區

第 2 章：南美洲和中美洲藥物輸送市場 - 關鍵要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲藥物輸送市場 - 市場格局

  • 概述
  • 南美洲和中美洲 PEST 分析
  • 專家意見

第 5 章：南美洲和中美洲藥物輸送市場 - 主要市場動態

  • 市場促進因素
    • 慢性病發生率上升
    • 對非侵入性給藥系統的需求不斷成長
    • 藥廠研發支出增加
  • 主要市場限制
    • 與藥物和輸送系統開發相關的高成本
    • 藥物輸送系統中的產品召回
  • 主要市場機會
    • 專注於提高病患依從性
  • 未來的趨勢
    • 策略發展和產品發布
  • 影響分析

第 6 章：藥物輸送市場 - 南美洲和中美洲分析

  • 南美洲和中美洲藥物輸送市場收入預測與分析

第 7 章：南美洲和中美洲藥物輸送市場 - 2028 年收入和預測 - 按給藥途徑

  • 概述
  • 南美洲和中美洲藥物輸送市場收入佔有率，按給藥途徑分類（2022 年和 2028 年）
  • 注射給藥
  • 口服給藥
  • 局部給藥
  • 經由黏膜給藥
  • 植入式藥物輸送
  • 眼部藥物輸送

第 8 章：南美洲和中美洲藥物輸送市場 - 2028 年收入和預測 - 按配銷通路

  • 概述
  • 南美洲和中美洲藥物輸送系統市場收入佔有率，按配銷通路（2022 年和 2028 年）
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 9 章：南美洲和中美洲藥物輸送市場 - 2028 年收入和預測 - 按最終用戶

  • 概述
  • 南美洲和中美洲給藥系統市場收入佔有率，按最終用戶分類（2022 年和 2028 年）
  • 醫院和診所
  • 家庭護理設置
  • 其他最終用戶

第 10 章：南美洲和中美洲藥物輸送市場 - 2028 年收入和預測 - 國家分析

      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地區

第 11 章：南美洲和中美洲藥物輸送市場 - 產業格局

  • 概述
  • 南美洲和中美洲給藥市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Becton Dickinson and Co
  • Novo Nordisk AS
  • Boston Scientific Corp
  • Baxter International Inc
  • Gerresheimer AG
  • GlaxoSmithKline Plc
  • 博士健康公司
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展
  • 勃林格殷格翰國際股份有限公司
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展
  • 諾華公司
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展
  • 塞弗製藥解決方案
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展
  • 強生公司
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展
  • 輝瑞公司
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展

    第 13 章：附錄

    • 關於 Insight Partners
    • 專業術語
    • Product Code: BMIRE00028763

    The South & Central America drug delivery market is expected to grow from US$ 1,09,189.07 million in 2023 to US$ 1,42,876.69 million by 2028. It is estimated to grow at a CAGR of 5.5% from 2023 to 2028.

    Growing Demand for Noninvasive Drug Delivery Systems Fuel South & Central America Drug Delivery Market

    Noninvasive drug delivery generally refers to methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to improved access to medicines, adherence to treatment regimes, and better drug safety profiles. Patients prefer noninvasive drug delivery routes due to such apparent advantages over injection-based drug administration. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure. With improvements in medical devices and transdermal delivery technologies, the noninvasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. Topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and delivery via an alveolar membrane from inhaled medication are a few of the popular noninvasive drug delivery methods.

    A low rejection rate, ease of administration, convenience, and durability make TDDS the most attractive method of drug delivery. In addition to pharmaceutical administration in medical facilities, TDDS could be used in different procedures in the skincare industry. Since this method mainly involves local administration, it can prevent nonspecific delivery to tissues that are not targeted by the drug. Developments in TDDS are likely to help control the prevalence of cardiovascular and central nervous system disorders, genetic disorders, diabetes, neuromuscular disorders, and infectious (including localized conditions) diseases while driving advancements in vaccination and patient preference for self-administration of drugs for long-term treatment.

    Drug delivery through noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. In many cases, the manufacturing cost of drugs with noninvasive delivery systems is lesser than the production costs of injections. For instance, inhaled insulin has emerged as a well-tolerated and preferred modality for treating diabetes. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery systems market.

    South & Central America Drug Delivery Market Overview

    The South & Central America drug delivery market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing import of medical devices, growing developments of healthcare systems that demand advanced medical technologies, increasing incidences of chronic diseases, and a rising geriatric population.

    South & Central America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)

    South & Central America Drug Delivery Market Segmentation

    The South & Central America drug delivery market is segmented into route of administration, distribution channel, end user, and country.

    Based on route of administration, the South & Central America drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held a larger share of the South & Central America drug delivery market in 2023.

    Based on distribution channel, the South & Central America drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the South & Central America drug delivery market in 2023.

    Based on end user, the South & Central America drug delivery market is segmented into hospitals and clinics, home care settings, and other end user. The hospitals and clinics segment held the largest share of the South & Central America drug delivery market in 2023.

    Based on country, the South & Central America drug delivery market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the share of the South & Central America drug delivery market in 2023.

    Bausch Health Companies Inc, Baxter International Inc, Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Novo Nordisk AS, and Pfizer Inc are the leading companies operating in the South & Central America drug delivery market.

    Reasons to Buy:

    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America drug delivery market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in South & Central America drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

    Table Of Contents

    1. Introduction

    • 1.1 Study Scope
    • 1.2 The Insight Partners Research Report Guidance
    • 1.3 Market Segmentation
      • 1.3.1 South & Central America Drug Delivery Market - by Route of Administration
      • 1.3.2 South & Central America Drug Delivery Market - by Distribution Channel
      • 1.3.3 South & Central America Drug Delivery Market - by End User
      • 1.3.4 South & Central America Drug Delivery Market - by Country

    2. South & Central America Drug Delivery Market - Key Takeaways

    3. Research Methodology

    • 3.1 Coverage
    • 3.2 Secondary Research
    • 3.3 Primary Research

    4. South & Central America Drug Delivery Market - Market Landscape

    • 4.1 Overview
    • 4.2 South & Central America PEST Analysis
    • 4.3 Expert's Opinion

    5. South & Central America Drug Delivery Market - Key Market Dynamics

    • 5.1 Market Drivers
      • 5.1.1 Rising Incidence of Chronic Diseases
      • 5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
      • 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
    • 5.2 Key Market Restraints
      • 5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
      • 5.2.2 Product Recalls in Drug Delivery Systems
    • 5.3 Key Market Opportunities
      • 5.3.1 Focus on Improving Patient Compliance
    • 5.4 Future Trends
      • 5.4.1 Strategic Developments and Product Launches
    • 5.5 Impact analysis

    6. Drug Delivery Market - South & Central America Analysis

    • 6.1 South & Central America Drug Delivery Market Revenue Forecast and Analysis

    7. South & Central America Drug Delivery Market - Revenue and Forecast to 2028 - By Route of Administration

    • 7.1 Overview
    • 7.2 South & Central America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
    • 7.3 Injectable Drug Delivery
      • 7.3.1 Overview
      • 7.3.2 Injectable Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.3.2.1 Conventional Injection Devices
          • 7.3.2.1.1 Overview
          • 7.3.2.1.2 Conventional Injection Devices: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.3.2.2 Advanced Devices
          • 7.3.2.2.1 Overview
          • 7.3.2.2.2 Advanced Devices: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4 Oral Drug Delivery
      • 7.4.1 Overview
      • 7.4.2 Oral Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.2.1 Solid Oral Drugs
          • 7.4.2.1.1 Overview
          • 7.4.2.1.2 Solid Oral Drugs: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.2.2 Liquid Oral Drugs
          • 7.4.2.2.1 Overview
          • 7.4.2.2.2 Liquid Oral Drugs: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.2.3 Semi-solid Oral Drugs
          • 7.4.2.3.1 Overview
          • 7.4.2.3.2 Semi-solid Oral Drugs: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.5 Topical Drug Delivery
      • 7.5.1 Overview
      • 7.5.2 Topical Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.1 Semi-solid Topical Drug Delivery
          • 7.5.2.1.1 Overview
          • 7.5.2.1.2 Semi-solid Topical Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.2 Liquid Topical Drug Delivery Formulations
          • 7.5.2.2.1 Overview
          • 7.5.2.2.2 Liquid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.3 Solid Topical Drug Delivery Formulations
          • 7.5.2.3.1 Overview
          • 7.5.2.3.2 Solid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.4 Transdermal
          • 7.5.2.4.1 Overview
          • 7.5.2.4.2 Transdermal Patches: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.6 Transmucosal Drug Delivery
      • 7.6.1 Overview
      • 7.6.2 Transmucosal Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.1 Pulmonary and Nasal Drug Delivery
          • 7.6.2.1.1 Overview
          • 7.6.2.1.2 Pulmonary and Nasal Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.2 Buccal and Sublingual Drug Delivery
          • 7.6.2.2.1 Overview
          • 7.6.2.2.2 Buccal and Sublingual Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.3 Rectal Transmucosal Drug Delivery
          • 7.6.2.3.1 Overview
          • 7.6.2.3.2 Rectal Transmucosal Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.4 Vaginal Transmucosal Drug Delivery
          • 7.6.2.4.1 Overview
          • 7.6.2.4.2 Vaginal Transmucosal Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.7 Implantable Drug Delivery
      • 7.7.1 Overview
      • 7.7.2 Implantable Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.8 Ocular Drug Delivery
      • 7.8.1 Overview
      • 7.8.2 Ocular Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.1 Eye Drops and Sprays
          • 7.8.2.1.1 Overview
          • 7.8.2.1.2 Eye Drops and Sprays: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.2 Gels and Ointments
          • 7.8.2.2.1 Overview
          • 7.8.2.2.2 Gels and Ointments: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.3 Ocular Inserts and Punctal Plugs
          • 7.8.2.3.1 Overview
          • 7.8.2.3.2 Ocular Inserts and Punctal Plugs: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.4 Therapeutic Contact Lens
          • 7.8.2.4.1 Overview
          • 7.8.2.4.2 Therapeutic Contact Lens: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)

    8. South & Central America Drug Delivery Market - Revenue and Forecast to 2028 - By Distribution Channel

    • 8.1 Overview
    • 8.2 South & Central America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
    • 8.3 Hospital Pharmacies
      • 8.3.1 Overview
      • 8.3.2 Hospital Pharmacies: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4 Retail Pharmacies
      • 8.4.1 Overview
      • 8.4.2 Retail Pharmacies: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.5 Online Pharmacies
      • 8.5.1 Overview
      • 8.5.2 Online Pharmacies: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

    9. South & Central America Drug Delivery Market - Revenue and Forecast to 2028 - By End User

    • 9.1 Overview
    • 9.2 South & Central America Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
    • 9.3 Hospitals and Clinics
      • 9.3.1 Overview
      • 9.3.2 Hospitals and Clinics: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.4 Home Care Settings
      • 9.4.1 Overview
      • 9.4.2 Home Care Settings: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.5 Other End User
      • 9.5.1 Overview
      • 9.5.2 Other End User: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

    10. South & Central America Drug Delivery Market - Revenue and Forecast to 2028 - Country Analysis

    • 10.1 Overview
      • 10.1.1 South & Central America Drug Delivery Market, by Country, 2022 & 2028 (%)
        • 10.1.1.1 Brazil: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.1.1 Overview
          • 10.1.1.1.2 Brazil: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.1.3 Brazil: South & Central America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.1.3.1 Brazil: South & Central America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.2 Brazil: South & Central America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.3 Brazil: South & Central America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.4 Brazil: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.5 Brazil: South & Central America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.4 Brazil: South & Central America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.1.5 Brazil: South & Central America Drug Delivery Market, by End User, 2020-2028 (US$ Million)
        • 10.1.1.2 Argentina: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.2.1 Overview
          • 10.1.1.2.2 Argentina: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.2.3 Argentina: South & Central America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.2.3.1 Argentina: South & Central America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.2 Argentina: South & Central America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.3 Argentina: South & Central America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.4 Argentina: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.5 Argentina: South & Central America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.4 Argentina: South & Central America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.2.5 Argentina: South & Central America Drug Delivery Market, by End User, 2020-2028 (US$ Million)
        • 10.1.1.3 Rest of South & Central America: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.3.1 Overview
          • 10.1.1.3.2 Rest of South & Central America: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.3.3 Rest of South & Central America: South & Central America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.3.3.1 Rest of South & Central America: South & Central America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.2 Rest of South & Central America: South & Central America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.3 Rest of South & Central America: South & Central America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.4 Rest of South & Central America: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.5 Rest of South & Central America: South & Central America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.4 Rest of South & Central America: South & Central America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.3.5 Rest of South & Central America: South & Central America Drug Delivery Market, by End User, 2020-2028 (US$ Million)

    11. South & Central America Drug Delivery Market - Industry Landscape

    • 11.1 Overview
    • 11.2 Growth Strategies in South & Central America Drug Delivery Market
    • 11.3 Organic Growth Strategies
      • 11.3.1 Overview
    • 11.4 Inorganic Growth Strategies
      • 11.4.1 Overview

    12. Company Profiles

    • 12.1 Becton Dickinson and Co
      • 12.1.1 Key Facts
      • 12.1.2 Business Description
      • 12.1.3 Products and Services
      • 12.1.4 Financial Overview
      • 12.1.5 SWOT Analysis
      • 12.1.6 Key Developments
    • 12.2 Novo Nordisk AS
      • 12.2.1 Key Facts
      • 12.2.2 Business Description
      • 12.2.3 Products and Services
      • 12.2.4 Financial Overview
      • 12.2.5 SWOT Analysis
      • 12.2.6 Key Developments
    • 12.3 Boston Scientific Corp
      • 12.3.1 Key Facts
      • 12.3.2 Business Description
      • 12.3.3 Products and Services
      • 12.3.4 Financial Overview
      • 12.3.5 SWOT Analysis
      • 12.3.6 Key Developments
    • 12.4 Baxter International Inc
      • 12.4.1 Key Facts
      • 12.4.2 Business Description
      • 12.4.3 Products and Services
      • 12.4.4 Financial Overview
      • 12.4.5 SWOT Analysis
      • 12.4.6 Key Developments
    • 12.5 Gerresheimer AG
      • 12.5.1 Key Facts
      • 12.5.2 Business Description
      • 12.5.3 Products and Services
      • 12.5.4 Financial Overview
      • 12.5.5 SWOT Analysis
      • 12.5.6 Key Developments
    • 12.6 GlaxoSmithKline Plc
      • 12.6.1 Key Facts
      • 12.6.2 Business Description
      • 12.6.3 Products and Services
      • 12.6.4 Financial Overview
      • 12.6.5 SWOT Analysis
        • 12.6.5.1 Key Developments
    • 12.7 Bausch Health Companies Inc
      • 12.7.1 Key Facts
      • 12.7.2 Business Description
      • 12.7.3 Products and Services
      • 12.7.4 Financial Overview
      • 12.7.5 SWOT Analysis
      • 12.7.6 Key Developments
    • 12.8 Boehringer Ingelheim International GmbH
      • 12.8.1 Key Facts
      • 12.8.2 Business Description
      • 12.8.3 Products and Services
      • 12.8.4 Financial Overview
      • 12.8.5 SWOT Analysis
      • 12.8.6 Key Developments
    • 12.9 Novartis AG
      • 12.9.1 Key Facts
      • 12.9.2 Business Description
      • 12.9.3 Products and Services
      • 12.9.4 Financial Overview
      • 12.9.5 SWOT Analysis
      • 12.9.6 Key Developments
    • 12.10 Sever Pharma Solutions
      • 12.10.1 Key Facts
      • 12.10.2 Business Description
      • 12.10.3 Products and Services
      • 12.10.4 Financial Overview
      • 12.10.5 SWOT Analysis
      • 12.10.6 Key Developments
    • 12.11 Johnson & Johnson
      • 12.11.1 Key Facts
      • 12.11.2 Business Description
      • 12.11.3 Products and Services
      • 12.11.4 Financial Overview
      • 12.11.5 SWOT Analysis
      • 12.11.6 Key Developments
    • 12.12 Pfizer Inc
      • 12.12.1 Key Facts
      • 12.12.2 Business Description
      • 12.12.3 Products and Services
      • 12.12.4 Financial Overview
      • 12.12.5 SWOT Analysis
      • 12.12.6 Key Developments

    13. Appendix

    • 13.1 About The Insight Partners
    • 13.2 Glossary of Terms

    List Of Tables

    • Table 1. Brazil: South & Central America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 2. Brazil: South & Central America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 3. Brazil: South & Central America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 4. Brazil: South & Central America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 5. Brazil: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 6. Brazil: South & Central America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 7. Brazil: South & Central America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 8. Brazil: South & Central America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 9. Argentina: South & Central America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 10. Argentina: South & Central America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 11. Argentina: South & Central America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 12. Argentina: South & Central America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 13. Argentina: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 14. Argentina: South & Central America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 15. Argentina: South & Central America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 16. Argentina: South & Central America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 17. Rest of South & Central America: South & Central America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 18. Rest of South & Central America: South & Central America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 19. Rest of South & Central America: South & Central America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 20. Rest of South & Central America: South & Central America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 21. Rest of South & Central America: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 22. Rest of South & Central America: South & Central America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 23. Rest of South & Central America: South & Central America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 24. Rest of South & Central America: South & Central America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 25. Recent Organic Growth Strategies in South & Central America Drug Delivery Market
    • Table 26. Recent Inorganic Growth Strategies in the South & Central America Drug Delivery Market
    • Table 27. Glossary of Terms, South & Central America Drug Delivery Market

    List Of Figures

    • Figure 1. South & Central America Drug Delivery Market Segmentation
    • Figure 2. South & Central America Drug Delivery Market by Country
    • Figure 3. South & Central America Drug Delivery Market Overview
    • Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in South & Central America Drug Delivery Market
    • Figure 5. Brazil Expected to Show Remarkable Growth During Forecast Period
    • Figure 6. South & Central America: PEST Analysis
    • Figure 7. Experts' Opinion
    • Figure 8. South & Central America Drug Delivery Market Impact Analysis of Drivers and Restraints
    • Figure 9. South & Central America Drug Delivery Market- Revenue Forecast and Analysis - 2020-2028
    • Figure 10. South & Central America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
    • Figure 11. Injectable Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 12. Conventional Injection Devices: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 13. Advanced Devices: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 14. Oral Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 15. Solid Oral Drugs: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 16. Liquid Oral Drugs: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 17. Semi-solid Oral Drugs: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 18. Topical Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 19. Semi-solid Topical Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 20. Liquid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 21. Solid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 22. Transdermal Patches: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 23. Transmucosal Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 24. Pulmonary Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 25. Buccal and Sublingual Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 26. Rectal Transmucosal Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 27. Vaginal Transmucosal Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 28. Implantable Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 29. Ocular Drug Delivery: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 30. Eye Drops and Sprays: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 31. Gels and Ointments: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 32. Ocular Inserts and Punctal Plugs: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 33. Therapeutic Contact Lens: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 34. South & Central America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
    • Figure 35. Hospital Pharmacies: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 36. Retail Pharmacies: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 37. Online Pharmacies: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 38. South & Central America Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
    • Figure 39. Hospitals and Clinics: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 40. Home Care Settings: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 41. Other End User: South & Central America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 42. South & Central America Drug Delivery Market, by Key Country - Revenue (2022) (US$ Million)
    • Figure 43. South & Central America Drug Delivery Market, by Country, 2022 & 2028 (%)
    • Figure 44. Brazil: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 45. Argentina: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 46. Rest of South & Central America: South & Central America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 47. Growth Strategies in South & Central America Drug Delivery Market